Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Defects in TGFβ signaling overcome senescence of mouse keratinocytes expressing v-rasHa

Abstract

Previous studies have shown that TGFβ1 expression is upregulated in mouse keratinocytes infected with a v-rasHa retrovirus, although the functional significance of this has not been clear. Here we show that v-rasHa retrovirus transduced primary mouse keratinocytes undergo hyperproliferation followed by a TGFβ1 dependent G1 growth arrest and senescence. The growth arrest is accompanied by a 15-fold increase in total TGFβ1 secreted and a fourfold increase in secreted active TGFβ1. When cultured in the presence of a neutralizing antibody to TGFβ1, the senescence response is suppressed. Levels of the TGFβ1 target p15ink4b increase during senescence as does association of this kinase inhibitor with cyclinD/cdk4 complexes. However, p16ink4a, p53 and p19ARF expression also increase during senescence. Genetic analysis shows that TGFβ1 null and dominant negative TβRII expressing v-rasHa keratinocytes resist the G1 growth arrest and do not senescence. This resistance is associated with low expression of p15ink4b and p16ink4a, constitutive Rb phosphorylation and high levels of cdk4 and cdk2 kinase activity. In contrast, inactivation of TGFβ1 secretion or response does not block the induction of p53 and p19ARF, but the level of p21waf1, a p53 target gene, is reduced in cyclin D/cdk4 and cyclin E/cdk2 complexes. Thus, although multiple senescence pathways are activated in response to a ras oncogene, inactivation of TGFβ1 secretion or response is sufficient to block the senescence program. Since v-rasHa transduced TGFβ1−/− keratinocytes form squamous cell carcinomas following skin grafting, these results suggest that in mouse keratinocytes, defects in TGFβ1 signaling accelerate malignant progression by overcoming oncogene induced replicative senescence.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D and Barrett JC . 1996 Proc Natl Acad Sci USA 93: 13742–13747

  • Aldaz CM, Trono D, Larcher F, Slaga TJ and Conti CJ . 1989 Mol Carcinog 2: 22–26

  • Alexandrow MG and Moses HL . 1995 Perspect Cancer Res 30: 1–2

  • Amendt C, Schirmacher P, Weber H and Blessing M . 1998 Oncogene 17: 25–34

  • Arteaga CL, Carty-Dugger T, Moses HL, Hurd SD and Pietenpol JA . 1993 Cell Growth Differ 4: 193–201

  • Balmain A and Pragnell IB . 1983 Nature 303: 72–74

  • Balmain A, Ramsden M, Bowden GT and Smith J . 1984 Nature 307: 658–660

  • Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL and Vousden KH . 1998 Nature 395: 124–125

  • Bond J, Haughton M, Blaydes J, Gire V, Wynford-Thomas D and Wyllie F . 1996 Oncogene 13: 2097–2104

  • Bos JL . 1988 Mutat Res 195: 255–271

  • Bottinger EP, Jakubczak JL, Haines DC, Bagnall K and Wakefield LM . 1997a Cancer Res 57: 5564–5570

  • Bottinger EP, Jakubczak JL, Roberts IS, Mumy M, Hemmati P, Bagnall K, Merlino G and Wakefield LM . 1997b EMBO J 16: 2621–2633

  • Bremner R and Balmain A . 1990 Cell 61: 407–417

  • Brown K, Quintanilla M, Ramsden M, Kerr IB, Young S and Balmain A . 1986 Cell 46: 447–456

  • Buchmann A, Ruggeri B, Klein-Szanto AJP and Balmain A . 1991 Cancer Res 51: 4097–4101

  • Burns PA, Kemp CJ, Gannon JV, Lane DP, Bremner R and Balmain A . 1991 Oncogene 6: 2363–2369

  • Campisi J . 1993 Ann NY Acad Sci 195–201

  • Chang HL, Gillett N, Figari I, Lopez AR, Palladino MA and Derynck R . 1993 Cancer Res 53: 4391–4398

  • Cui W, Kemp CJ, Duffie E, Balmain A and Akhurst RJ . 1994 Cancer Res 54: 5831–5836

  • Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A and Akhurst RJ . 1996 Cell 86: 531–542

  • Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y and Wang XF . 1995 Proc Natl Acad Sci USA 92: 5545–5549

  • Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I and Pereira-Smith O . 1995 Proc Natl Acad Sci USA 92: 9363–9367

  • Dlugosz AA, Glick AB, Tennenbaum T, Weinberg WC and Yuspa SH . 1995 Methods in Enzymology Isolation and utilization of epidermal keratinocytyes for oncogene research Vogt PK and Verma IM eds Academic Press New York pp 3–20

    Google Scholar 

  • Drexler HG . 1998 Leukemia 12: 845–859

  • Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL and Attisano L . 1996 Cell 86: 543–552

  • Felsher DW and Bishop JM . 1999 Proc Natl Acad Sci USA 96: Suppl 3940–3944

  • Feng XH, Filvaroff EH and Derynck R . 1995 J Biol Chem 270: 24237–24245

  • Friedman E, Gold LI, Klimstra D, Zeng ZS, Winawer S and Cohen A . 1995 Cancer Epidemiol Biomarkers Prev 4: 549–554

  • Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M and Beach D . 1995 Science 269: 1575–1577

  • Garrigue-Antar L, Munoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF and Reiss M . 1995 Cancer Res 55: 3982–3987

  • Glick AB, Kulkarni AB, Tennenbaum T, Hennings H, Flanders KC, O'Reilly M, Sporn MB, Karlsson S and Yuspa SH . 1993 Proc Natl Acad Sci USA 90: 6076–6080

  • Glick AB, Lee MM, Darwiche N, Kulkarni AB, Karlsson S and Yuspa SH . 1994 Genes Dev 8: 2429–2440

  • Glick AB, Weinberg WC, Wu IH, Quan W and Yuspa SH . 1996 Cancer Res 56: 3645–3650

  • Go C, Li P and Wang XJ . 1999 Cancer Res 59: 2861–2868

  • Gorsch SM, Memoli VA, Stukel TA, Gold LI and Arrick BA . 1992 Cancer Res 52: 6949–6952

  • Grady WM, Rajput A, Myeroff L, Liu DF, Kwon K, Willis J and Markowitz A . 1998 Cancer Res 58: 3101–3104

  • Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE . 1996 Science 271: 350–353

  • Hannon GJ and Beach D . 1994 Nature 371: 257–261

  • Hartwell LH and Kastan MB . 1994 Science 266: 1821–1828

  • Herman JG, Jen J, Merlo A and Baylin SB . 1996 Cancer Res 56: 722–727

  • Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P, Tomlinson IP, Houlston RS, Bevan S, Mitros FA, Stone EM and Aaltonen LA . 1998 Science 280: 1086–1088

  • Husain Z, Yang QM and Biswas DK . 1990 Arch Dermatol Res 126: 324–330

  • Iavarone A and Massague J . 1997 Nature 387: 417–422

  • Kang SH, Won K, Chung HW, Jong HS, Song YS, Kim SJ, Bang YJ and Kim NK . 1998 Int J Cancer 77: 620–625

  • Kulkarni AB, Huh GG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM and Karlsson S . 1992 Proc Natl Acad Sci USA 90: 770–774

  • Laiho M, DeCaprio JA, Ludlow JW, Livingston DM and Massague J . 1990 Cell 62: 175–185

  • Li CY, Suardet L and Little JB . 1995 J Biol Chem 270: 4971–4974

  • Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G, Sherr CJ and Balmain A . 1995 Cancer Res 55: 5168–5172

  • Loughran O, Malliri A, Owens D, Gallimore PH, Stanley MA, Ozanne B, Frame MC and Parkinson EK . 1996 Oncogene 13: 561–568

  • Manning AM, Williams AC, Game SM and Paraskeva C . 1991 Oncogene 6: 1471–1476

  • Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M and Willson JKV . 1995 Science 268: 1336–1338

  • Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ and Kato JY . 1994 Mol Cell Biol 14: 2066–2076

  • Mietz JA, Unger T, Huibregtse JM and Howley PM . 1992 EMBO J 11: 5013–5020

  • Munger K, Pietenpol JA, Pittelkow MR, Holt JT and Moses HL . 1992 Cell Growth Differ 3: 291–298

  • Naumann M, Savitskaia N, Eilert C, Schramm A, Kalthoff H and Schmiegel W . 1996 Gastroenterology 110: 1215–1224

  • Palmero I, Pantoja C and Serrano M . 1998 Nature 395: 125–126

  • Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW and Vogelstein B . 1995 Cancer Res 55: 5548–5550

  • Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA . 1998 Cell 92: 713–723

  • Portella G, Cumming SA, Liddell J, Cui W, Ireland H, Akhurst RJ and Balmain A . 1998 Cell Growth Differ 9: 393–404

  • Quelle DE, Zindy F, Ashmun RA and Sherr CJ . 1995 Cell 83: 993–1000

  • Quintanilla M, Brown K, Ramsden M and Balmain A . 1986 Nature 322: 78–80

  • Reynisdottir I, Polyak K, Iavarone A and Massague J . 1995 Genes Dev 9: 1831–1845

  • Reznikoff CA, Yeager TR, Belair CD, Savelieva E, Puthenveettil JA and Stadler WM . 1996 Cancer Res 56: 2886–2890

  • Riggins GJ, Kinzler KW, Vogelstein B and Thiagalingam S . 1997 Cancer Res 57: 2578–2580

  • Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P, Tennant RW, Weinberg RA, Yuspa SH and Conti CJ . 1998 Genes Dev 12: 2469–2474

  • Roop DR, Lowy DR, Tambourin PE, Strickland J, Harper JR, Balaschak M, Spangler EF and Yuspa SH . 1986 Nature 323: 822–824

  • Ruddle FH and Creagan RP . 1975 Annu Rev Genet 9: 407–486

  • Sambrook J, Fritsch EF and Maniatis T . 1989 Molecular Cloning A Laboratory Manual, 2nd edn New York Cold Spring Harbor Laboratory Press

    Google Scholar 

  • Sandhu C, Garbe J, Bhattacharya N, Daksis J, Pan CH, Yaswen P, Koh J, Slingerland JM and Stampfer MR . 1997 Mol Cell Biol 17: 2458–2467

  • Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW . 1997 Cell 88: 593–602

  • Seth P, Rosenfeld M, Higginbotham J and Crystal RG . 1994 J Virol 68: 933–940

  • Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ and Weinberg RA . 1995 Cell 82: 621–630

  • Tang B, Bottinger EP, Jakowlew SB, Bagnall KM, Mariano J, Anver MR, Letterio JJ and Wakefield LM . 1998 Nature Med 4: 802–807

  • Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF and Massague J . 1992 Cell 71: 1003–1014

  • Xu HJ, Zhou Y, Ji W, Perng GS, Kruzelock R, Kong CT, Bast RC, Mills GB, Li J and Hu SX . 1997 Oncogene 15: 2589–2596

  • Yamamoto H, Ueno H, Ooshima A and Takeshita A . 1996 J Biol Chem 271: 16253–16259

  • Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM . 1992 Cell 70: 937–948

  • Yuspa SH, Vass W and Scolnick E . 1983 Cancer Res 43: 6021–6030

  • Yuspa SH . 1994 Cancer Res 54: 1178–1189

  • Zariwala M, Liu E and Xiong Y . 1996 Oncogene 12: 451–455

  • Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B and Kern SE . 1998 Mol Cell 1: 611–617

  • Zhang Y, Xiong Y and Yarbrough WG . 1998 Cell 92: 725–734

Download references

Acknowledgements

The authors thank Chris Lam for technical assistance, Brett Cheney for maintenance of transgenic and knockout mice and Dr Luowei Li for Adβgal, and Dr Fernandez-Salas for advice on purification of recombinant adenoviruses. We also thank Dr Dana Ramujak and Dr Beverly Mock for advice on the immuncomplex kinase assays, and Dr Stuart Yuspa and members of the Yuspa laboratory for helpful discussions and critical reading of the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tremain, R., Marko, M., Kinnimulki, V. et al. Defects in TGFβ signaling overcome senescence of mouse keratinocytes expressing v-rasHa. Oncogene 19, 1698–1709 (2000). https://doi.org/10.1038/sj.onc.1203471

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203471

Keywords

This article is cited by

Search

Quick links